Seattle Genetics Stock News

Seagen (SGEN) expects its portfolio of marketed drugs, which are approved for various cancer indications, to generate incremental sales and combat stiff competition.

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Sherwin-Williams Co (NYSE: SHW) might go lower as the PE (price-to-earnings) multiple is still "way too high" on the stock. When asked about

Seagen is now trading below the levels that implied a high probability of a buyout. Label expansion opportunities for approved products and the expanding pipeline will drive strong topline growth in t

Only one future study readout was talked about in Seagen's Q2 earnings call. However, six additional human trials are estimated to complete in the next 6 months.

Joe Terranova, Virtus Investment Partners chief market strategist, joins 'Closing Bell: Overtime' to discuss CNBC's Alpha Survey results and where he's looking in the market now.

Seagen (SGEN) signs an exclusive agreement with LAVA Therapeutics to develop and commercialize the latter's preclinical asset, LAVA-1223, targeting EGFR-expressing solid tumors.

Seagen (SGEN) signs an exclusive agreement with LAVA Therapeutics to develop and commercialize the latter's preclinical asset, LAVA-1223, targeting EGFR-expressing solid tumors.

Gainers LAVA Therapeutics N.V. (NASDAQ: LVTX) shares climbed 97.5% to close at $4.74 on Monday after the company and Seagen Inc (NASDAQ: SGEN) announced an exclusive license agreement in which Seage

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite turning negative on Monday. The Dow traded down 1.02% to 29,287.62 while the NASDAQ fell 0.22% to 10,843.61. The S&P 500 a

Gainers LAVA Therapeutics N.V. (NASDAQ: LVTX) shares jumped 97% to $4.71 after the company and Seagen Inc (NASDAQ: SGEN) announced an exclusive license agreement in which Seagen will work to develop

U.S. stocks traded mixed midway through trading, with the Dow Jones dropping more than 100 points on Monday. The Dow traded down 0.44% to 29,461.37 while the NASDAQ rose 0.30% to 10,900.05. The S&P 50

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 100 points on Monday. Following the market opening Monday, the Dow traded down 0.05% to 29,574.61 while the N

The billionaire investor is a big believer in betting on America.

The billionaire investor is a big believer in betting on America.

It hasn't taken huge returns to rank among the top three of the Dow this year.